A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male Volunteers

NCT02124213 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 30 mg PF-06412562
DRUG: PF-06412562
DRUG: PF-06412562

Sponsor

Pfizer